News | Cardiovascular Ultrasound | June 15, 2017

CPAP Therapy Improves Heart Function in Patients With Severe Obstructive Sleep Apnea

cardiac ultrasound echo used to assess CPAP patient cardiac improvement

June 15, 2017 – Obstructive sleep apnea (OSA) is a common sleep disorder affecting millions of people, roughly 4 percent of men and 2 percent of women. This disorder, in which a person stops breathing periodically during sleep, is also associated with left ventricular (LV) diastolic dysfunction. Researchers recently found a new therapy that shows promise to lessen the symptoms of this debilitating condition. 

Researchers explored the effects of continuous positive airway pressure (CPAP) therapy on the underlying mechanisms involving LV diastolic dysfunction. The comprehensive assessment was conducted using diastolic stress echocardiography and two dimensional (2-D) speckle tracking analysis. It demonstrated improved left ventricular diastolic function, as well as improvements in left and right ventricular strain parameters. “CPAP therapy significantly improves LV diastolic function in patients with severe OSA patients” said Darae Kim, M.D.
 
Researchers on the study, “Effect of Continuous Positive Airway Pressure Therapy on Left Ventricular Diastolic Function in Patients with Severe Obstructive Sleep Apnea (CPAP-OASIS) assessed by Tissue Doppler, 2D Speckle Tracking and Exercise Hemodynamics: A Randomized Sham Controlled Clinical Trial,” included Darae Kim, Chi Young Shim, Sungha Park, Jong-Won Ha, Geu-Ru Hong, and Namsik Chung of Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; and Yang-Je Cho of Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
 
Kim presented a poster based on this research during the Arthur E. Weyman Young Investigator’s Award Competition at the recent 2017 meeting of the American Society of Echocardiography (ASE).

 

Related Content of Sleep Apnea and the Heart

Study Suggests Ways to Block Hypertension in Sleep Apnea Patients

Implantable Device Improved Central Sleep Apnea, Reduces Heart Failure Complications

Statins May Lower Heart Disease Risk in People with Sleep Apnea

 

For more information: ASEcho.org


Related Content

News | Cardiovascular Ultrasound

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

Home April 05, 2024
Home
News | Cardiovascular Ultrasound

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

Home August 24, 2023
Home
News | Cardiovascular Ultrasound

July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...

Home July 27, 2023
Home
Feature | Cardiovascular Ultrasound

February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...

Home February 10, 2023
Home
Feature | Cardiovascular Ultrasound | By Paul M Bojarski

Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is ...

Home August 23, 2022
Home
News | Cardiovascular Ultrasound

August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...

Home August 09, 2022
Home
News | Cardiovascular Ultrasound

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to ...

Home July 07, 2022
Home
News | Cardiovascular Ultrasound

June 15, 2022 — Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non ...

Home June 15, 2022
Home
Subscribe Now